E poxyeicosatrienoic acids (EETs) are products of epoxygenation of arachidonic acid. They participate in cardiovascular regulation via vasodilator and natriuretic effects. Research on their actions used urine or plasma measurements of their 4 active regioisomers (5, 8, 11, and 14, and their relatively inactive derivatives, the dihydroxyeicosatrienoic acids [DHETs]. The latter are produced by enzymatic (soluble epoxide hydrolase [sEH]) or nonenzymatic (eg, pH, oxidative stress) degradation.
poxyeicosatrienoic acids (EETs) are products of epoxygenation of arachidonic acid. They participate in cardiovascular regulation via vasodilator and natriuretic effects. Research on their actions used urine or plasma measurements of their 4 active regioisomers (5,6-, 8,9-, 11,12-, and 14,15-EETs) and their relatively inactive derivatives, the dihydroxyeicosatrienoic acids [DHETs] . The latter are produced by enzymatic (soluble epoxide hydrolase [sEH]) or nonenzymatic (eg, pH, oxidative stress) degradation.
Previous studies in animals suggested that urine and plasma EETs may reflect 2 distinct pools with different functions. The volume of distribution of intravenous radiolabeled 14,15-EET in dogs approximates their plasma volume, and no radioactivity can be detected in their urine. 1 Plasma EET responses to regulatory PPARα (peroxisome proliferatoractivated receptor α) ligands in mice run parallel to Cyp2c epoxygenase expression and EET biosynthesis in the liver. 2 These studies suggest that plasma EETs reflect a systemic, not a renal pool. Conversely, increased renal EET content produced by dopamine agonists in mice is not associated with changes in plasma EETs, 3 indicating that the renal EET pool might be better reflected by urine measurements. Our first aim was to assess whether these putative pools could be uncovered by studying clinical and biochemical correlates of urine and plasma EETs in normal volunteers; that is, normotensive, saltresistant (SR) subjects, during salt loading and depletion.
EETs may play a role in salt sensitivity of blood pressure (BP). Salt stimulates renal microsomal biosynthesis of EETs in normal Sprague Dawley 4 and Dahl-R rats, 5 whereas this response is absent in the salt-sensitive (SS) Dahl-S strain, leading to hypertension with reduced renal expression of the epoxygenase CYP2C23 and urine excretion of EETs. 5 In SR rats, the epoxygenase inhibitor clotrimazole decreases urinary EETs and reproduces SS hypertension. 5 Cyp4a10 knockout mice, which have reduced renal epoxygenase (Cyp2c44) activity, 6 and the Cyp2c44 knockout, 7 have diminished urine EETs and amiloride-sensitive hypertension. This is associated with decreased inactivating threonine phosphorylation of γENaC (epithelial sodium channel), 7 which is reversible by the PPARα ligands that stimulate epoxygenases. 6 Our second aim was to investigate whether SS subjects exhibit differences in urine or plasma EETs levels or in their responses to changes in salt balance or in their clinical or biochemical correlates compared with SR. To avoid confounding effects of established hypertension, we performed these studies in normotensive volunteers.
Abstract-We measured epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs) in 21 normotensive subjects classified as salt resistant (13) or salt sensitive (8) with an inpatient protocol of salt loading (460 mEq Na + /24 hours, HiNa) and depletion (10 mEq Na + /24 hours+furosemide 40 mg×3, LoNa). No urine EETs were detected; hence, enzyme linked innumosorbent assay 14,15-DHETs (dihydroxyeicosatrienoic acids) were considered the total converted 14,15-urine pool. We report ultra-performance liquid chromatography/tandem mass spectrometry plasma EETs, DHETs, and their sum (plasma total pool) for the 3 regioisomers (8,9-, 11,12-, 14,15-) and their sum (08,15-). In salt-resistant subjects, urine total pool was unchanged by HiNa, decreased by LoNa, and correlated with urine sodium excretion, fractional excretion of Na + , and Na + /K + ratio for the 3 days of the experiment combined (P<0.03). In contrast, plasma total pool increased in LoNa and did not correlate with natriuresis or Na + /K + ratio but showed correlations between EETs, blood pressures, and catecholamines and between DHETs and aldosterone (P<0.03). Urine total pool of salt-sensitive was lower than that of salt-resistant subjects in certain phases of the experiment, lacked responses to changes in salt balance, and exhibited limited correlations with natriuresis and Na + /K + ratio during LoNa only. Plasma total pool of salt-sensitive was lower than in salt-resistant subjects and did not correlate with blood pressures or aldosterone but did with catecholamines. We conclude that the urine total pool reflects a renal pool involved in regulation of natriuresis, whereas the plasma total pools are of systemic origin, uninvolved in Na + excretion, perhaps contributing to regulation of vascular tone. Data suggest that abnormalities in EETs in salt-sensitive subjects participate in their renal or vascular dysfunction, which has potential therapeutic implications. (Hypertension.
Methods
The authors declare that all supporting data are available within the article (and its online-only Data Supplement).
Subjects and Protocol
A total of 21 normotensive volunteers participated in an institutional review board-approved (Scott and White Hospital) protocol to assess salt sensitivity of BP and to measure urine and plasma epoxyeicosatrienoic acids (EETs and DHETs). After 2 weeks on their habitual salt intake, we obtained demographic and clinical characteristics, physical examinations, and routine laboratory data. We verified that there were no excluding illnesses and that BP was <140 mm Hg systolic and <90 diastolic. Subjects brought a 24-hour urine specimen and were admitted to the research ward the night before starting a protocol adapted from Grim et al 8 as previously reported. 9 Briefly, after baseline clinical and laboratory data (base day), subjects had a 460 mEq Na + load (160 mEq in metabolic kitchen diet and 2 L intravenous normal saline from 8:00 am to 12:00 noon; salt loading or HiNa day). The next morning, after obtaining clinical and laboratory data representing salt loading, salt depletion was produced with an isocaloric 10 mEq Na + /d diet and 3 oral 40 mg doses of furosemide at ≈8:00 am, 12:00 noon, and 4:00 pm (LoNa day). The following morning, subjects were discharged from the hospital after obtaining clinical and laboratory data representing salt depletion. Potassium intake was 70 mEq/d, and oral fluid intake was ad libitum throughout the study. BP (SpaceLabs 90207) was recorded every 15 minutes from 6:00 am to 10:00 pm and every 30 minutes overnight. Baseline BP was the average from awakening on HiNa until starting the saline infusion. HiNa BP was the average from 12:00 noon (after the saline infusion) until 10:00 pm (time to retire to bed), and LoNa BP was the average from 12:00 noon (after the second dose of furosemide) until 10:00 pm. A fall in systolic BP ≥10 mm Hg from HiNa to LoNa was used to classify a subject as SS. Body weights were measured daily, on awakening.
Laboratory data included blood counts, chemistries with electrolytes and creatinine, plasma renin activity, aldosterone and insulin (radioimmunoassay), and plasma catecholamines (radioenzymatic assay). Insulin sensitivity was the HOMA2-S index (Homeostatic Model Assessment; www.dtu.ox.ac.uk). 10 Urine specimens for 4 periods (24-hour base day, 24-hour HiNa day, 12-hour LoNa day for furosemide-induced diuresis, and 12-hour LoNa day for salt depletion) were collected on ice and stored at −80°C without additives. The 12-hour periods for LoNa were chosen based on previous experience with duration of furosemide diuresis (10-11 hours) . Data for the 12-hour salt depletion period were doubled for comparison with the 24-hour samples, analogous to using per hour data. Volumes, creatinines, and electrolytes were recorded for each period. Creatinine clearance and fractional excretion of sodium were calculated.
Measurement of Urinary EETs and DHETs
Active EETs were not detected by 2 different liquid chromatography/tandem mass spectrometry methods (see online-only Data Supplement), which we attributed to long-term storage of the samples despite freezing at −80°C. Therefore, we measured levels of 14,15-DHET with a commercial enzyme linked immunosorbent assay kit (Eagle Biosciences) that uses a specific antibody (<3% cross-reactivity with other DHETs and <1% with other eicosanoids and like lipids). Results of these measurements were considered the urine total pool (UTP) of 14,15-epoxyeicosatrienoic acids.
Measurement of Plasma EETs and DHETs
Plasma EETs and DHETs were quantified in samples frozen and stored at −80°C using a previously published ultra-performance liquid chromatography/tandem mass spectrometry method 11 (see online-only Data Supplement). The main comparisons are between the total pools of epoxyeicosatrienoic acids in urine (14,15-UTP) and the plasma total pools (08,15-PTP). Separate data for 08,15-EET and DHET, calculated activity of sEH (sEH=DHET/ [EET+DHET]), and all data for each regioisomer are given in the online-only Data Supplement.
Statistical Analyses
Epoxyeicosatrienoic acids, plasma aldosterone, and salt excretion were not normally distributed (Shapiro-Wilk) and are presented as log-transformed data, which became normally distributed data sets without outliers (Grubb test). Values are presented as mean±SEM. Comparisons between SS and SR subjects were made with unpaired Student t tests. Changes in parameters produced by changes in salt balance within the same subjects were analyzed with paired t tests. Correlation coefficients were calculated with Pearson method. All these tests and singlelinear regression analyses were performed with JMP software (SAS Institute). A probability <5% was used to reject the null hypothesis. No subanalyses by sex or race were conducted owing to small n's.
Results

Characteristics of the Participants
Data on the 21 subjects (who had participated in a previously published study 12 ) are in Table. Eight (38%) were classified as SS on the basis of their responses to salt depletion. There were no differences in age, sex distribution, renal function, or plasma catecholamines between SS and SR. Urine sodium excretion on an ad libitum diet at home was similar to or higher than that of the average US population in both groups and did not differ between them. BPs were <140/90 mm Hg in both groups but were significantly albeit slightly higher in SS than in SR. Some traditional features of the SS phenotype (eg, hyperinsulinemia, insulin resistance, and atherogenic P values are for the comparison of SR vs SS. Their absence indicates lack of statistical significance. Aldo indicates plasma aldosterone; B, black; BMI, body mass index; ClCr, creatinine clearance; DBP, diastolic blood pressure; F, female; HDL, high-density lipoprotein; HOMA2-S, insulin sensitivity index; M, male; PRA, plasma renin activity; SBP, systolic blood pressure; ∆SBP (LoNaHiNa), decrease in blood pressure from the high-salt to the low-salt day; SR, salt resistant; SS, salt sensitive; UNaV, urine sodium excretion; and W, white. February 2018 dyslipidemia) were significantly different between SS and SR, whereas others (eg, larger percent of black subjects, obesity, and suppression of the renin-angiotensin-aldosterone system) showed only nonsignificant trends.
EET and DHET Levels in Urine and Plasma of Normal (SR) Subjects and Their Responses to Changes in Salt Balance
In normal (SR) subjects (open symbols, Figure 1 ), neither 14,15-UTP nor 08,15-PTP was changed by salt loading ( Figure 1A and 1B) . Lack of change in 08,15-PTP by salt resulted from decreased sEH activity and DHETs with concomitant increase in plasma 08,15-EETs (consistent in all regioisomers and significant for some; ‡ in Table S1 in the online-only Data Supplement). In contrast, salt depletion produced opposite significant decreases in 14,15-UTP ( Figure 1A ) versus increases in 08,15-PTP ( Figure 1B) . The latter were because of increased plasma sEH activity and DHETs (consistent in all regioisomers and significant for some; § in Table S1 ) with concomitant albeit not significant increase in EETs. Hence, 14,15-UTP responses to salt depletion were consistent with those expected in a natriuretic system, whereas plasma epoxyeicosatrienoic acids changed in the opposite direction.
EET and DHET Levels in Urine and Plasma of SS Subjects and Their Responses to Changes in Salt Balance
14,15-UTP of SS was slightly but not significantly lower than in SR on all days combined ( Figure 1C ) and significantly lower on ad libitum salt intake at baseline ( Figure 1A ). In contrast, 08,15-PTP of SS was significantly lower than that of SR on all days combined ( Figure 1D ), a product of a significant difference in the high-salt day and a borderline difference in the low-salt day ( Figure 1B) . Decreased 08,15-PTP of SS compared with SR was attributable to lower levels of EETs during salt loading and DHETs during salt depletion (* and † for the regioisomers in Table S1 ), without differences in sEH activity.
14,15-UTP responses to changes in salt balance were blunted in SS compared with SR, with their levels on an ad libitum diet at baseline being in the same range as those during salt depletion ( Figure 1A ). Plasma 08,15-PTP of SS decreased during salt loading because of decreased 11,12-and 14,15-DHETs ( ‡ in Table S1 ). In contrast, it increased during salt depletion ( Figure 1B ) because of increased DHET of all regioisomers ( § in Table S1 ), similar to changes in SR.
In summary, lower plasma EETs in SS than SR throughout the experiment, despite almost identical activity of sEH, (paired t test) . P values are for significant or borderline differences in levels between SS and SR subjects (unpaired t test). SR indicates salt resistant; and SS, salt sensitive.
suggest a deficit in either the expression or the activity of epoxygenases. Furthermore, plasma responses to salt loading and depletion in SS were inconsistent with those expected from a natriuretic system.
UTP Correlates in a Different Manner With Natriuresis and Activity of the Epithelial Sodium Channel in SR and SS Subjects
In SR, 14,15-UTP of the 3 days combined correlated with absolute natriuresis, fractional excretion of sodium, and most importantly with the urine Na + /K + ratio, a marker of inhibition of ENaC (Figure 2, left) + ratio during the baseline or salt loading periods, analyzed separately or together. Moreover, only 1 UTP datapoint of SS (during salt loading) slightly exceeded the maximum UTP excretion during salt depletion.
In neither SR nor SS was there any correlation between plasma epoxyeicosatrienoic acid fractions and urine sodium excretion or Na + /K + ratio (not shown). Briefly, data suggest that UTP of SR reflects a renal pool involved in regulation of Na + excretion in normal humans. The correlation between 14,15-UTP and inhibition of ENaC indicates that even after conversion to the diols in our samples, their measurement reflects the activity of this putative renal pool.
In contrast, the restricted correlations in SS between UTP and either natriuresis or Na + /K + ratio suggest abnormalities in EETdependent natriuresis and ENaC inhibition in SS normotension.
Plasma EETs Correlate With Arterial Pressure in SR But Not SS Subjects
In SS, there were no significant correlations between urine or plasma epoxyeicosatrienoic acids (PTP, EET, or DHET) and BPs (Table S2) .
In SR, this was also true for urine epoxyeicosatrienoic acids ( Figure 3A) . In contrast, there were significant correlations between arterial pressures and plasma 08,15-EETs A B Figure 3 . In salt-resistant (SR) subjects, no correlations between 14,15-UTP (A) and systolic blood pressure (SBP), diastolic blood pressure (DBP), or mean arterial pressure (MAP) but significant correlations between 08,15-EET (B) and all blood pressures for the 3 days of the experiment. Symbols for each day as in Figure 1 . Pearson r coefficients and their statistical significance are given on the graphs. ns indicates not significant.
( Figure 3B ). These were not observed for DHETs ( Figure  S1B ) but carried over to 08,15-PTPs ( Figure S1A ). Analogous observations were present for all regioisomers (Table S2) . Furthermore, correlations between 08,15-EET and arterial pressure were present for the 3 days analyzed together and also for the 2 days with relatively high-salt intake (base and HiNa combined; r=0.40; P<0.05) and for the 2 days with a widely different range of sodium intake (HiNa and LoNa combined; r=0.46; P<0.02).
Plasma DHETs Correlate With Plasma Aldosterone in SR But Not SS Subjects
Baseline plasma aldosterone was slightly but not significantly lower in SS than in SR (Table) . Its suppression by salt was blunted in the former group (∆log HiNa-LoNa: SS −0.03±0.04, ns versus SR −0.07±0.04; P<0.04) as described previously, whereas its stimulation by salt depletion was similar in both groups (SS 0.30±0.06 versus SR 0.35±0.05).
In SR, there was a significant correlation between aldosterone and 08,15-PTP (r=0.39; P<0.02), entirely attributable to 08,15-DHETs, not 08,15-EETs, and without a correlation between aldosterone and 08,15-sEH activity ( Figure 4A ). The correlation aldosterone/DHET was also significant for the 11,12-and 14,15-plasma regioisomers in all days or in the base+Hi and Hi+Lo days but was not present for UTP (Table S3) .
In contrast, in SS, there was no correlation between any urine or plasma epoxyeicosatrienoic acid fraction and aldosterone ( Figure 4B ; Table S3 ).
Plasma EETs Correlate With Plasma Catecholamines in Both SR and SS Subjects
Baseline plasma catecholamines of SR and SS (346±50 pg/ mL) did not change after the salt load (348±42, ns) but were stimulated by salt depletion (418±36; P<0.03).
In both SR and SS, there was a correlation between plasma norepinephrine and 08,15-EET, not present for epinephrine or dopamine ( Figure 5 ). It was highly significant for both groups together (r=0.43; P<0.001) and reflected in a correlation between total catecholamines and 08,15-EETs (r=0.45; P<0.0005).
Also, there was no correlation between norepinephrine and 08,15-DHET in either group, but the effect of EET carried over to a significant one with 08,15-PTP ( Figure S2 ). This figure also shows that there was no correlation between UTP and catecholamines in either group.
The correlations EET-norepinephrine and their lack thereof for DHETs were consistent for all regioisomers. They were present for the 3 days and also for the 2 days of high-salt intake (base+Hi) with narrow variance of catecholamines and over the days of salt loading and depletion (Hi+Lo), with wide variance of catecholamines (Table S4 ).
Discussion
Our 2 major observations are as follows: First, in normal (SR) volunteers, responses of urine and plasma epoxyeicosatrienoic acids to changes of salt balance are of opposite direction, and their clinical and biochemical correlates are different. This supports our hypothesis that they reflect 2 different pools (renal tubular versus systemic), perhaps synthesized independently and with different functions. Second, SS subjects have diminished urine and plasma levels of these eicosanoids compared with SR with paradoxical or absent responses to changes in salt balance. Also correlations between their urine levels, natriuresis, and ENaC function are restricted to low levels of Na + excretion. Finally, relationships between plasma levels and vasoactive substances identified in SR are lacking in SS. All these findings suggest involvement of abnormalities in epoxyeicosatrienoic acids in the pathophysiology of the SS phenotype in humans, consistent with observations in rodents.
In SR, urine epoxyeicosatrienoic acids were inhibited by salt depletion as expected for a natriuretic system. However, their excretion was not increased by salt loading (inconsistent with stimulation of renal epoxygenases by salt in rodents 4, 5 ). Because ad libitum salt intake of our subjects was 15-fold greater than that in primitive societies, it is possible that renal EETs are maximally stimulated at the current level of salt consumption in Western societies.
Our observations that urine (not plasma) epoxyeicosatrienoic acids correlate with natriuresis and inhibition of ENaC in normal humans are novel but expected in view of the natriuretic role for renal EETs in rodents. Evidence includes (1) stimulation of renal epoxygenases by salt, 4, 5 (2) rapid decrease in open probability of collecting duct ENaC by an EET-induced, ERK1/2 (extracellular signal-regulated kinases)-catalyzed, inactivating threonine phosphorylation of its β and γ subunits, 7 (3) slower sustained inhibition of ENaC by an EET-activating dephosphorylation of the ubiquitin ligase Nedd4-2, 13 which induces removal of the channel from the membrane, 14 and (4) mediation of proximal tubule dopamine-induced water and sodium excretion by EETs, demonstrated by its blunting in Cyp2c44 −/− epogygenase knockout mice. 3 Therefore, in normal humans, urine epoxyeicosatrienoic acids most likely reflect the activity of a renal tubular pool that regulates ENaC activity and natriuresis. Hence, research on the renal actions of epoxyeicosatrienoic acids in humans must rely on their urine, not plasma measurements.
Plasma levels of epoxyeicosatrienoic acids of normal humans sustained changes opposite to those of UTP in response to changes in salt balance and exhibited different correlates compared with those of UTP. Suppression of sEH and DHET and mild stimulation of EETs by salt suggest a compensatory response to enhance vasodilation during a salt load, whereas stimulation of sEH and DHET by low-salt balance may diminish vasodilation for maintenance of BP during salt depletion.
Positive correlations between a vasodilator and higher BP in SR suggest that endothelial synthesis of EETs is stimulated by higher BP to exert counter-regulatory vasodilator tone. Although no such evidence has been published, this speculation is consistent with increased vasodilator tone in normotensive or hypertensive experimental models when production of vascular EETs is enhanced by dietary means 15 or by administration of EET analogs. 16 These observations likely reflect EET attenuation of vascular myogenic responses in resistance arterioles, as shown in sEH knockout mice or with sEH inhibitors. 17 The correlation between DHET and plasma aldosterone in SR could reflect parallel dichotomization of both parameters by changes in salt balance (inhibition by salt loading and stimulation by salt depletion). However, it was also present during the periods of small variance of aldosterone levels (baseline and high-salt days). Because EET release by adrenal zona glomerulosa cells is not accompanied by aldosterone release, 18 this correlation is unlikely to reflect effects of EETs on aldosterone synthase. Conversely, stimulation of expression or activity of epoxygenases or sEH by aldosterone has never been reported. Finally, we found no relationship between aldosterone and sEH and have no data to alternatively support aldosterone-induced DHET formation by oxidative stress. 19 The relationship might reflect a feed-forward effect of aldosterone inhibiting its counter-regulatory system to enhance extrarenal effects on ENaC, but we have no data in this regard. Therefore, the physiological significance of this relationship remains to be investigated.
Plasma EETs and catecholamines were also affected by salt balance in parallel manner (no change with salt loading and stimulation by salt depletion). However, their correlations were present for the periods of narrow (baseline and high salt) and large (high salt and low salt) variances in plasma catecholamines. They were present in both SR and SS and highly significant in all subjects together. Previously reported relationships between epoxyeicosatrienoic acids and the autonomic nervous system include (1) arachidonic acid mediated by endogenous 5,6-EET, which can be blocked by CYP450 inhibitors and restored by exogenous 5, ; (2) coexpression of epoxygenases and sEH in brain parasympathetic perivascular nerves 21 ; and (3) production of EETs by sympathetic superior cervical ganglia neurons in culture. 22 Mechanisms for these interactions have not been elucidated, and there is no evidence for either catecholamine stimulation of epoxygenases or for EET-induced norepinephrine release from sympathetic terminals in whole animals or humans. Reciprocal stimulation of these vasodilator and vasoconstrictor systems suggests a regulatory interaction for maintenance of normal vascular tone and BP or for systemic noncardiovascular effects of the autonomic nervous system, but these are speculations.
Salt sensitivity of BP is a common phenotype of normotensive and hypertensive subject by which BP varies in parallel to salt intake. It confers increased cardiovascular morbidity and mortality compared with SR. 23, 24 Although a cardiovascular risk factor, it has no specific treatment because its mechanisms are not completely understood. A deficit in the production or actions of the natriuretic or vasodilator EETs, or in both, could participate in the pathophysiology of the SS phenotype via renal or vascular dysfunction, its 2 putative major mechanisms. 25, 26 A B Figure 5 . Significant correlations between 08,15-epoxyeicosatrienoic acids (EET) and plasma norepinephrine but not epinephrine or dopamine in salt-resistant (SR; A) and salt-sensitive (SS; B) subjects. Symbols for SR and SS and for the 3 days of the experiment are as in Figure 1 . Zero values (below the limit of detection) are arbitrarily spread around zero for better visualization. Pearson r coefficients and their statistical significance are given on the graphs. ns indicates not significant. February 2018 SS had lower levels of 14,15-UTP compared with SR for the 3 days of the study, reaching significance at baseline, despite their UNaV being 40 mmol/d greater than that of SR. Furthermore, baseline levels were not different than those observed after profound salt depletion, and although stimulated by salt, they did not reach the baseline levels of SR ( Figure 1A) . Three interpretations are possible: First, SS may have a defect upstream of renal epoxygenase expression (eg, salt sensing), but this is not supported by the correlation between UTP and natriuresis at low levels of Na + excretion. Second, they may have defective renal expression of epoxygenases. This is supported by our results, those of a dietary experiment, in which SS had diminished urine EETs during the low-salt phase, 27 and by reduced renal expression of epoxygenases and urine excretion of EETs in Dahl-S rats. 5 Third, a defect may be downstream of the EETs, impairing signaling to renal sodium transporters. This would be analogous to our description of lack of natriuretic effect for normal urine 20-HETE (hydroxyeicosatetraenoic acid) in SS hypertension 9 and strongly supported by the observation that excretion of UTP per unit UNaV was markedly increased in SS compared with SR.
Plasma EETs were significantly lower for the 3 phases of the study in SS than in SR, most strikingly after the salt load ( Figure 1B ). In the dietary study mentioned above, SS also had lower plasma EET than SR albeit during the lowsalt period. 27 Rather than a flat pattern with changes in salt intake (as their UTP exhibited), SS had decreased plasma sEH and DHETs with salt loading and increased EETs and DHETs with salt depletion, again analogous to the dietary study. 27 These responses are not consistent with those of a natriuretic system. Finally, equal to SR, no plasma epoxyeicosatrienoic acid fraction of SS correlated with natriuresis or inhibition of ENaC. Therefore, it is extremely unlikely that diminished plasma epoxyeicosatrienoic acids of SS contribute to the SS phenotype via renal tubular (ie, natriuresis) abnormalities.
Our data are consistent with evidence that plasma epoxyeicosatrienoic acids belong in a systemic, that is, nonrenal tubular compartment.
1,2 Changes in plasma sEH, DHETs, and EETs and correlations with norepinephrine in SS suggest involvement in compensatory vasodilation. This is surprising because the major hemodynamic abnormality of SS is an inability to vasodilate in response to salt loading. 12 However, these changes took place at lower levels of plasma epoxyeicosatrienoic acids in SS than SR, which may explain this apparent contradiction. Lack of correlation between plasma EETs of SS and BP, present in normal SR subjects, supports dysregulated vasodilation by EETs in SS.
Weaknesses of our study include (1) power calculations were made for the previously reported hemodynamic studies in the same subjects, 12 not specifically for the current one; therefore, we may have been underpowered to show more dramatic differences in levels between SR and SS, many of which were of borderline significance when analyzed for single day lower n's. However, despite this, we documented a different set of correlates for urine and plasma measurements, that is, the small n's did not preclude detection of significant relationships. (2) Inability to detect active EETs in urine samples, different from other studies, 1, 27, 28 was most likely produced by nonenzymatic conversion to DHETs during prolonged storage. The relative proportion of EETs and DHETs at collection must have been different in each patient, and this unknown variance should have weakened our statistical analyses. Therefore, the detectable and strong correlation between UTP and Na + /K + ratio, a marker of ENaC inhibition, makes us confident that measuring the total pool of urine epoxyeicosatrienoic acids as converted relatively inactive diols did nonetheless reflect the activity of this pool at the time the samples were obtained. (3) The only available enzyme linked immunosorbent assay for urine DHET measures the 14,15-regioisomer, whereas our plasma methods measured the 8,9-, 11,12-, and 14,15-regioisomers. Although results with the plasma regioisomers were indistinguishable from those of the sum of the 3 regioisomers, we could not ascertain whether this was true in our urine samples. (4) Our conclusions are derived in part from correlations, which do not imply causality and should be considered hypothesis generating, to be tested by pharmacological intervention.
Overall, our studies show different regulation by salt and different clinical and biochemical correlates for urine and plasma epoxyeicosatrienoic acids in humans. They suggest that urine data reflect a renal tubular pool involved in regulation of natriuresis, whereas plasma data reflect a systemic pool unrelated to salt excretion, most likely participating in regulation of vasodilation, maintenance of normal BP, or perhaps noncardiovascular effects that we have not investigated. In addition, we describe differences between SS and SR subjects that support participation of epoxyeicosatrienoic acids in the renal or vascular pathophysiology of the SS phenotype, consistent with beneficial effects of EET analogs and sEH antagonist observed in experimental models of SS hypertension.
29,30
Perspectives
Two broad implications are derived from our studies. First, research on the renal physiology of epoxyeicosatrienoic acids in humans, in the absence of tissue samples, must rely on measurements of urine epoxyeicosatrienoic acids, whereas in contrast, research on the multiple systemic actions of epoxyeicosatrienoic acids (cardiovascular or otherwise) must rely on plasma measurements. Second, our data encourage investigation of potential use of EET analogs and sEH antagonist (both in development) in the SS phenotype of normotensive or hypertensive subjects, a cardiovascular risk factor that currently has no specific therapy.
